Literature DB >> 16819319

Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases.

Lara R Harik1, Celine Merino, Jean-Michel Coindre, Mahul B Amin, Florence Pedeutour, Sharon W Weiss.   

Abstract

Inflammatory pseudotumor or pseudosarcomatous fibromyxoid tumor and postoperative spindle cell nodule of the bladder are unusual lesions of uncertain pathogenesis which share overlapping, if not identical, histologic features. We present our experience with 42 cases, the largest series to date, to study the etio-pathogenesis, histologic features, biologic behavior and relationship to "inflammatory myofibroblastic tumor" of childhood. Patients ranged in age from 7 to 77 years (mean 47 y) and males predominated (3.2:1). Most patients presented with hematuria (31/42). Common associations were smoking (10/30) and previous instrumentation or surgery (9/42). The clinicopathologic features of patients having or not having prior instrumentation were identical. Grossly the lesions were polypoid or nodular and involved any portion of bladder wall, most commonly the dome (9/27) and measured 1 to 10 cm (mean 4 cm). They were composed of spindled and stellate cells arranged in a myxoid background with numerous inflammatory cells. Myxoid hypocellular areas were more pronounced near the mucosal surface with greater cellularity and a fascicular arrangement in the deep aspect of the lesion. "Atypical" features included mitotic activity (0 to 20/10 HPF; mean 2/10 HPF; median 1/10 HPF; none atypical), necrosis (22/42), and extension into muscularis propria (28/32) or perivesicular fat (3/8). Lesions were positive for cytokeratin (31/33), SMA (23/34), desmin (21/35), and Alk-1 protein (12/26). FISH confirmed the Alk-1 translocation in 4/6 cases. Treatment included transurethral resection (30/42), partial cystectomy (9/42), and total cystectomy (3/42). Initial diagnostic error resulted in radiotherapy and chemotherapy in 3 patients. Follow-up was available in 28 patients. (range 3 to 93 mo; median 25 mo). Three patients developed recurrences, but none had metastases. Because the clinicopathologic features of lesions associated with and without instrumentation were similar and inseparable, we believe they are essentially the same entity, and propose the term pseudosarcomatous myofibroblastic proliferation. The preponderance of evidence which includes the extravesical growth, local recurrence, and Alk-1 gene translocation in some cases suggests perhaps a neoplastic process with limited growth potential. Even in the face of atypical histologic features (muscle invasion and necrosis) the prognosis is excellent. Despite the Alk-1 gene translocation, there continues to be sufficient evidence for regarding these as distinct from the so-called inflammatory myofibroblastic tumor of childhood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819319     DOI: 10.1097/01.pas.0000208903.46354.6f

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

1.  Invasive urothelial carcinoma with chordoid features of the ureter: a rare entity and review of literature.

Authors:  Jianguo Wei; Zhenying Yue; Dianhang Song; Qiang Wang; Xiaodong Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Inflammatory myofibroblastic tumor of the urinary bladder managed by laparoscopic partial cystectomy.

Authors:  Manas Ranjan Pradhan; Priyadarshi Ranjan; Ram Nawal Rao; Saurabh Sudhir Chipde; Krishna Pradhan; Rakesh Kapoor
Journal:  Korean J Urol       Date:  2013-11-06

3.  Inflammatory myofibroblastic tumour of the bladder: Case report and review of the literature.

Authors:  Li Wei; Liang Jianbo; Wei Qiang; Yu Hai; Lan Zhixiang
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

Review 4.  [Mesenchymal tumors of the urinary bladder].

Authors:  A Agaimy; A Hartmann
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

5.  Pseudosarcomatous myofibroblastic tumour of the urinary bladder: a case report.

Authors:  K Chandramouleeswari; S Anita; B Shivali
Journal:  J Clin Diagn Res       Date:  2012-10

Review 6.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

7.  Dysuria and fever in a young woman diagnosed as having inflammatory myofibroblastic tumour of the urinary bladder.

Authors:  Shashikant Chandrakant Urmila Patne; Richa Katiyar; Deepshikha Chaudhary; Sameer Trivedi
Journal:  BMJ Case Rep       Date:  2016-02-15

8.  Inflammatory Myofibroblastic Bladder Tumor in a Patient with Von Recklinghausen's Syndrome.

Authors:  Eleftherios Chatzidarellis; Evangelos Mazaris; Andreas Skolarikos; Demonakou Maria; Iraklis Mitsogiannis; Nafsika Mousiou; Apostolos Bisas
Journal:  Case Rep Med       Date:  2010-08-08

9.  Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining.

Authors:  Ram Nawal Rao; Priydarshi Ranjan; Nidhi Singla; Rakesh Pandey
Journal:  Urol Ann       Date:  2012-05

10.  Relevance of inflammatory pseudotumor associated with bladder tumor.

Authors:  Annamma Kurien; Joseph Thomas; Sreedhar Reddy; Arun Chawla
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.